Fatal drug contamination like a 2008 incident involving Baxter International Inc. (BAX)’s blood thinner Heparin that sickened and killed hundreds is inevitable unless the agency gets enhanced inspection and recall powers for non-U.S. factories, a top regulator said. Another crisis is “not a matter of if, it’s a matter of when,” Deborah Autor, the Food and Drug Administration’s deputy commissioner for global regulatory operations and policy, told a U.S. Senate committee today.
